Skip to main content
ALK-Abelló logo

ALK-Abelló — Investor Relations & Filings

Ticker · ALK ISIN · DK0061802139 LEI · 529900SGCREUZCZ7P020 CO Manufacturing
Open in API
Filings indexed 1,210 across all filing types
Latest filing 2015-08-31 Regulatory Filings
Country DK Denmark
Listing CO ALK

About ALK-Abelló

https://www.alk.net

ALK-Abelló is a global, research-driven pharmaceutical company specializing in the prevention, diagnosis, and treatment of allergies. The company is a world leader in allergy immunotherapy (AIT), also known as allergy vaccination, which is a disease-modifying treatment that targets the underlying cause of the allergy rather than just the symptoms. Its portfolio includes a range of allergy treatments and services, with products such as injections, sublingual tablets, and emergency treatments for severe allergic reactions like anaphylaxis. With over a century of experience, ALK-Abelló focuses on developing pharmaceutical products to improve the quality of life for people with allergies globally.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2015
Regulatory Filings Classification · 100% confidence The document announces the successful completion of the registration procedure for ALK's house dust mite (HDM) sublingual allergy immunotherapy (SLIT) tablet in 11 European countries. It discusses the product's indication, CEO commentary on the significance of the approval, and future availability timelines. Crucially, it also announces a conference call for analysts and investors to review the label of the tablet, which is a common practice accompanying significant corporate news or regulatory milestones. Since the text is an announcement of a major corporate/product development and includes details about an upcoming conference call to discuss it, it is best classified as a general corporate announcement or news release. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for significant, non-standardized corporate news that doesn't fit ER, IR, or CAP, although it strongly resembles an Earnings Release structure (announcement + call details). However, since it is focused on product registration/approval rather than financial results, RNS is the best fit among the provided codes for a significant, non-financial-period-specific corporate update.
2015-08-31 English
Earnings Release 2015
Earnings Release Classification · 100% confidence The document provides unaudited performance figures for Q2 and H1, including revenue, EBITDA, and guidance adjustments for the full year 2015. It details specific financial metrics and operational updates for a defined reporting period. This structure is characteristic of an Earnings Release (ER), which announces key financial results for a period, rather than a comprehensive Annual Report (10-K) or a detailed Management Discussion & Analysis (MDA). The text explicitly mentions hosting a conference call to review these 'financial results and the outlook,' confirming its nature as an initial results announcement. H1 2015
2015-08-18 English
Earnings Release 2015
Earnings Release Classification · 100% confidence The document provides detailed financial performance figures for Q2 and H1 (half-year), including revenue, EBITDA, and guidance adjustments. The text explicitly mentions 'halvårsrapporten' (the half-year report) and presents comprehensive financial data for a period shorter than a year. This strongly indicates an Interim/Quarterly Report. Although it contains a brief mention of an upcoming conference call, the primary content is the financial results summary, making 'IR' (Interim / Quarterly Report) the most appropriate classification over 'CT' (Call Transcript) or 'ER' (Earnings Release, which is usually just highlights). The length (under 5,000 characters) and the mention of the conference call suggest this might be the press release accompanying the full report, but the core content is the half-year financial summary, aligning best with IR. H1 2015
2015-08-18 English
Report Publication Announcement 2015
Report Publication Announcement Classification · 98% confidence The document is a short announcement (1041 characters) dated August 10, 2015, stating that ALK will release its interim report for the six months ended June 30, 2015, on August 18, 2015. It also provides details for an accompanying conference call and mentions that the related presentation will be available shortly before the call. Because the document is an announcement about the publication of a report (Interim Report) and the associated call/presentation, rather than the report itself, it fits the definition of a Report Publication Announcement (RPA). This aligns with the 'MENU VS MEAL' rule, as it is a short notice about a forthcoming report.
2015-08-10 English
Report Publication Announcement 2015
Report Publication Announcement Classification · 98% confidence The document is very short (approx. 1000 characters) and explicitly announces the future publication date (August 18, 2015) of the 'delårsrapport for første halvår (Q2) 2015' (Interim Report for the first half year/Q2 2015). It also announces a subsequent conference call and where the presentation will be available. According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement about the publication of a report, rather than the report itself, should be classified as a Report Publication Announcement (RPA).
2015-08-10 Danish
Regulatory Filings 2015
Regulatory Filings Classification · 95% confidence The document is a press release dated August 7, 2015, announcing positive Phase II/III study results for an allergy treatment tablet developed by ALK and its Japanese partner, Torii Pharmaceutical. It details clinical outcomes, quotes the CEO, and outlines next steps (submission to Japanese health authorities). This type of announcement, focusing on specific clinical trial results or significant business developments outside of routine financial reporting (like earnings or annual reports), is best classified as a general Regulatory Filing (RNS) or potentially an Investor Presentation (IP) if it were a slide deck. Given the format is a news release detailing a specific event/result, and it doesn't fit the strict definitions of ER, IR, 10-K, or CT, RNS serves as the most appropriate general regulatory announcement category. Since it is not explicitly announcing the *publication* of a separate report (which would be RPA), RNS is chosen.
2015-08-07 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.